logo
logo

NAMSA acquires WuXi AppTec's medical device testing operations in the U.S. to strengthen its position in medical technology testing and clinical research

NAMSA acquires WuXi AppTec's medical device testing operations in the U.S. to strengthen its position in medical technology testing and clinical research

01/17/25, 10:46 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CN.svgshanghai
Industry
pharmaceutical
biotechnology
manufacturing
NAMSA announces the definitive agreement to acquire WuXi AppTec's medical device testing operations in the United States, aiming to expand its range of clinical research and testing solutions for customers. This strategic acquisition aligns with NAMSA's commitment to accelerating innovation in medical technology and supporting sponsors in delivering life-saving medical technology worldwide.

Company Info

Company
NAMSA
Company info
NAMSA is a world-leading MedTech testing, clinical, and regulatory consulting firm dedicated to accelerating medical device product development. With a deep pool of testing, clinical, and regulatory experts, NAMSA helps medical device sponsors improve healthcare and is committed to enhancing stakeholder value through strategic outsourcing and comprehensive in-house services.

Related People